Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Sales | 7,671,500 | 6,550,500 | 5,939,500 | 5,061,300 | 4,128,900 |
| Cost of Goods | 1,778,100 | 1,550,300 | 1,526,100 | 1,444,300 | 1,338,000 |
| Gross Profit | 5,893,400 | 5,000,200 | 4,413,400 | 3,617,000 | 2,790,900 |
| Operating Expenses | 3,242,100 | 2,764,200 | 2,546,700 | 2,248,100 | 1,749,700 |
| Operating Income | 2,651,400 | 2,236,300 | 1,866,800 | 1,369,200 | 1,041,200 |
| Other Income | 47,400 | 46,700 | 4,200 | 36,000 | 32,100 |
| Pre-tax Income | 2,698,800 | 2,283,000 | 1,871,000 | 1,405,200 | 1,073,300 |
| Income Tax | 917,600 | 787,600 | 664,200 | 498,800 | 397,600 |
| Net Income Continuous | 1,781,200 | 1,495,400 | 1,206,800 | 906,400 | 675,700 |
| Net Income | $1,781,200 | $1,495,400 | $1,206,800 | $906,400 | $675,700 |
| EPS Basic Total Ops | 0.76 | 0.63 | 0.51 | 0.37 | 0.27 |
| EPS Basic Continuous Ops | 1.30 | 1.26 | 1.02 | 0.77 | 0.27 |
| EPS Diluted Total Ops | 1.30 | 1.26 | 1.02 | 0.77 | N/A |
| EPS Diluted Continuous Ops | 1.30 | 1.26 | 1.02 | 0.77 | N/A |
| EBITDA(a) | $2,905,400 | $2,458,000 | $2,071,700 | $1,579,200 | $1,041,200 |